Food labeling litigation increased significantly last year, with many consumer groups alleging that products were misleadingly labeled and violated U.S. Food and Drug Administration labeling requirements.
On January 31, 2017, the General Counsel of the National Labor Relations Board released an official memorandum declaring that scholarship football players at some of the most elite college programs are employees under the National Labor Relations Act.
Partner Marylee Jenkins, a leader in the New York office’s Intellectual Property group, has been reappointed a member and designated Chairperson of the United States Patent and Trademark Office’s Patent Public Advisory Committee for a three-year term.
New York partner Michelle Marsh was recently quoted in an article by Inside Counsel that explores the trademark infringement lawsuits associated with the Oscars.
On January 20, 2017, President Trump’s Chief of Staff, Reince Priebus, issued a memorandum implementing an immediate regulatory freeze of any new or pending regulations until they have been reviewed and approved by Trump Administration appointees.
An Executive Order from President Trump’s first days in office raised questions about its impact on the hard-won Privacy Shield, which allows about 1,700 companies to legally transfer data between the EEA and Switzerland and the US.
Earlier this month, FDA finalized Guidance for Industry, Assessment of Abuse Potential of Drugs. This guidance is intended to assist researchers and sponsors of new drugs that may have central nervous system (CNS) activity evaluate whether the drug has abuse potential.
The recent Bloomberg BNA article in both the Health Care Daily Report and Medicare Report “Health Fraud Rule Withdrawal May Hurt Enforcement Efforts” discussed how fraud enforcement efforts in the health care industry may be hindered by the Trump Administration.
In this episode of Fashion Counsel, Partners Anthony Lupo and Michelle Marsh discuss copyright laws and their applications (and road blocks) to the retail sector.
For the second consecutive year, International Trade partner David Hamill and Canada-US.Cross Border Business Affairs director Birgit Matthiesen contributed their insights to Lead, Reach and Connect, the must-read magazine for the Automotive Parts Manufactures Association.
Former Senator and Arent Fox Senior Policy Advisor Byron Dorgan (D-ND) spoke with Fox Business News along with former Senator Judd Gregg (R-NH) on whether President Trump is on the right track in the early days of his Administration.
In an interview with Dope Magazine, Food and Drug associate Emily Leongini discusses how the US Food and Drug Administration (FDA) is currently responding to the proliferation of state-legalized cannabis and how that could impact the growing cannabis industry.
As the newly-announced co-chair for the Institute for Representative Government (IRG), former Rep. Philip English, a senior advisor in the Government Relations practice at Arent Fox LLP, will help bring together elected officials from around the world to facilitate exchanging ideas and views.
Arent Fox LLP is pleased to announce that the firm negotiated an exceptional carve-out on behalf of Volkswagen dealer Palisades Volkswagen in a nationwide VW dealer diesel scandal class action settlement – the largest ever of its kind.
On January 9, New York Intellectual Property leader Marylee Jenkins was named Chair of the Patent Public Advisory Committee by The US Department of Commerce’s United States Patent and Trademark Office. This will be Ms. Jenkins’ second full term as a PPAC Member.
What is most notable about this guidance is that FDA has taken the position that this type of information may be shared before a product has been approved.
Today, January 19, 2017, FDA and USDA published a flurry of new policy documents related to the agencies’ regulation of plants, animals, and microorganisms produced using new breeding methods, like gene editing.